Essex Investment Management CO LLC Savara Inc Transaction History

Essex Investment Management CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$1.91 - $4.08 $95,500 - $204,000	-50,000 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$0.71 - $4.91 $35,500 - $245,500	50,000 New	50,000 $224,000
Q4 2018 Feb 06, 2019	SELL	$6.27 - $10.92 $101,153 - $176,172	-16,133 Closed	0 $0
Q3 2018 Oct 16, 2018	SELL	$10.49 - $12.87 $111,256 - $136,499	-10,606 Reduced 39.66%	16,133 $180,000
Q2 2018 Jul 17, 2018	BUY	$8.55 - $13.76 $228,618 - $367,928	26,739 New	26,739 $303,000

129

158M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $383M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.